Target intelligence / Profile preview

Ribosomal protein L35a pseudogene 22 (RPL35AP22)

Target: RPL35AP22
Molecular classification: Other (Processed pseudogene)

Overview

Ribosomal protein L35a pseudogene 22 (RPL35AP22) is a human processed pseudogene that is a noncoding genomic sequence related to the protein-coding gene for ribosomal protein L35a. RPL35AP22 was formed by retrotransposition, copying mRNA of the parent gene back into the genome, which resulted in a version of the gene incapable of producing functional protein. As a pseudogene, RPL35AP22 does not have protein-coding or regulatory functions, nor is it involved as a therapeutic target, biomarker, or disease gene[1][3][4][5][7].

Other names: RPL35A_9_1011RPL35AP22

Biological functions

Other (No known biological function; noncoding pseudogene)

Disease associations

Other (No direct disease association)

Beyond the preview

Go deeper on Ribosomal protein L35a pseudogene 22 (RPL35AP22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L35a pseudogene 22 (RPL35AP22).

Explore the full profile